These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Continuous intravenous home treatment of airway infections using ceftazidime administration via portable pump in patients with cystic fibrosis; a multicenter study]. Bakker W, Vinks AA, Mouton JW, de Jonge P, Verzijl JG, Heijerman HG. Ned Tijdschr Geneeskd; 1993 Nov 27; 137(48):2486-91. PubMed ID: 8272124 [Abstract] [Full Text] [Related]
4. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E, Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient. Clin Microbiol Infect; 2005 Sep 27; 11(9):690-703. PubMed ID: 16104983 [Abstract] [Full Text] [Related]
5. Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Gappa M, Steinkamp G, Tümmler B, von der Hardt H. Scand J Gastroenterol Suppl; 1988 Sep 27; 143():74-6. PubMed ID: 3164515 [Abstract] [Full Text] [Related]
6. Azlocillin in cystic fibrosis. Malmborg AS, Alfredsson H, Strandvik B. Isr J Med Sci; 1983 Nov 27; 19(11):1001-3. PubMed ID: 6662681 [Abstract] [Full Text] [Related]
15. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis. Permin H, Koch C, Høiby N, Christensen HO, Møller AF, Møller S. J Antimicrob Chemother; 1983 Jul 27; 12 Suppl A():313-23. PubMed ID: 6352636 [Abstract] [Full Text] [Related]
16. Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis. Strandvik B, Malmborg AS, Alfredson H, Ericsson A. J Antimicrob Chemother; 1983 Jul 27; 12 Suppl A():283-7. PubMed ID: 6352633 [Abstract] [Full Text] [Related]
17. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa. Béghin L, Michaud L, Loeuille GA, Wizla-Derambure N, Sayah H, Sardet A, Thumerelle C, Deschildre A, Turck D, Gottrand F. Pediatr Pulmonol; 2009 May 27; 44(5):464-71. PubMed ID: 19360849 [Abstract] [Full Text] [Related]
18. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. Knudsen PK, Olesen HV, Høiby N, Johannesson M, Karpati F, Laerum BN, Meyer P, Pressler T, Lindblad A, Scandinavian CF Study Consortium (SCFSC). J Cyst Fibros; 2009 Mar 27; 8(2):135-42. PubMed ID: 19157995 [Abstract] [Full Text] [Related]
19. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis. Mastella G, Agostini M, Barlocco G, Bonomi U, Borgo G, Bozzino L, Cabrini G, Cappelletti LM, Castellani L, Conforti M. J Antimicrob Chemother; 1983 Jul 27; 12 Suppl A():297-311. PubMed ID: 6311788 [Abstract] [Full Text] [Related]
20. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants]. Bégué P, Michel B, Chasalette JP, Allouche G, Quinet B. Pathol Biol (Paris); 1986 May 27; 34(5):525-9. PubMed ID: 3534737 [Abstract] [Full Text] [Related] Page: [Next] [New Search]